Company in Sunnyvale CA creates rapid COVID-19 Tests
PROVIDENCE, R.I (WLNE) – The molecular diagnostics company Cepheid developed a rapid test for COVID-19 that was approved by the United States Food and Drug Administration (FDA).
With Approval from the FDA, Cepheid has the authorization to distribute these tests to hospitals and other medical facilities.
According to the Chief Medical & Technology Officer of Cepheid, Dr. David Persing, the test can be run in about 45 minutes.
“During this time of increased demand for hospital services, Clinicians urgently need an on-demand diagnostic test for real-time management of patients being evaluated for admission to health-care facilities. An accurate test delivered close to the patient can be transformative — and help alleviate the pressure that the emergence of the 2019-nCoV outbreak has put on healthcare facilities that need to properly allocate their respiratory isolation resources,” said Dr. Persing.
According to Cepheid, the tests will begin shipping next week.
The cost of the test is not known at this time.